Clinical Trial Update: Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in Asthmatics [Phase 1, Phase 2]

View source ↗

Summary

This update reports a Phase 1/2 safety and efficacy trial of a sodium pyruvate bronchodilator for moderate asthma, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Sodium pyruvate (sodium pyruvate)

Snippet

Sponsor: Emphycorp | Conditions: Moderate Asthma | Phase 1, Phase 2 | Status: TERMINATED